Methods for treating gout
US12121566B2 · kind B2 · utility
0Cited by
194References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2020 |
| Grant date | Oct 22, 2024 |
| Priority date | — |
| Expiry date | Jan 12, 2041 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P19/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides methods of treating gout in patients comprising administering a PEGylated uricase. Also provided are methods of treating gout in patients comprising co-administering a PEGylated uricase and azathioprine immunosuppressive therapy. Also provided are methods of reducing intolerance or enhancing immuno-tolerance to a PEGylated uricase and prolonging the urate lowering effect comprising co-administration of the PEGylated uricase and azathioprine immunosuppressive therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.